The hyper-inflammatory SARS-CoV-2-induced ARDS patient micro-environment licenses MSCs and enhances their therapeutic efficacy in a model of acute lung injuryCourteney Tunstead, Karen English, Ritu Negi et al.|Unknown|2024Cited by 1